4.3 Article

Phase II randomised, placebo-controlled, clinical trial of interleukin-1 receptor antagonist in intracerebral haemorrhage: BLOcking the Cytokine IL-1 in ICH (BLOC-ICH)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Intracerebral haemorrhage

Laurent Puy et al.

Summary: Intracerebral haemorrhage (ICH) is a serious condition caused by the rupture of a cerebral vessel and the entry of blood into the brain parenchyma. It is a major cause of stroke-related mortality and dependency, with limited treatment options available. This Primer provides a comprehensive overview of the epidemiology, pathophysiology, diagnosis, and treatment of ICH, highlighting the importance of prevention and management of haematoma expansion and long-term vascular risk.

NATURE REVIEWS DISEASE PRIMERS (2023)

Article Clinical Neurology

Stages of the Inflammatory Response in Pathology and Tissue Repair after Intracerebral Hemorrhage

Michael H. Askenase et al.

SEMINARS IN NEUROLOGY (2016)

Article Clinical Neurology

Interleukin-1 in Stroke From Bench to Bedside

Oluwaseun A. Sobowale et al.

STROKE (2016)

Review Biotechnology & Applied Microbiology

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

Charles A. Dinarello et al.

NATURE REVIEWS DRUG DISCOVERY (2012)

Article Clinical Neurology

Natural Course of Perihemorrhagic Edema After Intracerebral Hemorrhage

Dimitre Staykov et al.

STROKE (2011)

Article Clinical Neurology

A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients

HCA Emsley et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)

Review Immunology

Interleukin-1 and neuronal injury

SM Allan et al.

NATURE REVIEWS IMMUNOLOGY (2005)